China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
China Traditional Chinese Medicine Holdings Co Ltd
Revenue
China Traditional Chinese Medicine Holdings Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Revenue
¥18.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
29%
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Revenue
HK$10.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Revenue
¥13.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Revenue
¥26.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Revenue
HK$244.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Revenue
$838m
|
CAGR 3-Years
54%
|
CAGR 5-Years
31%
|
CAGR 10-Years
34%
|
See Also
What is China Traditional Chinese Medicine Holdings Co Ltd's Revenue?
Revenue
18.1B
CNY
Based on the financial report for Dec 31, 2023, China Traditional Chinese Medicine Holdings Co Ltd's Revenue amounts to 18.1B CNY.
What is China Traditional Chinese Medicine Holdings Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
29%
Over the last year, the Revenue growth was 27%. The average annual Revenue growth rates for China Traditional Chinese Medicine Holdings Co Ltd have been 7% over the past three years , 10% over the past five years , and 29% over the past ten years .